Skip to content

Neogen NEOG Free cash flow

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$234.26M+12.7%
Zoetis logo
ZoetisZTS
$291M-13.6%
Agilent Technologies logo
Agilent TechnologiesA
$201M+87.9%
Revvity logo
RevvityRVTY
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's free cash flow?
Neogen (NEOG) reported free cash flow of $11.07M in Q4 2025.
How has Neogen's free cash flow changed year-over-year?
Neogen's free cash flow increased by 182.3% year-over-year, from -$13.45M to $11.07M.
What is the long-term trend for Neogen's free cash flow?
Over 2 years (2021 to 2024), Neogen's free cash flow has grown at a 20.3% compound annual growth rate (CAGR), from $54.38M to -$78.65M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.